Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Lifeloc Technologies (LCTC) Cash & Equivalents (2016 - 2025)

Lifeloc Technologies has reported Cash & Equivalents over the past 14 years, most recently at $746001.0 for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 40.02% year-over-year to $746001.0; the TTM value through Dec 2025 reached $746001.0, down 40.02%, while the annual FY2025 figure was $746001.0, 40.02% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $746001.0 at Lifeloc Technologies, up from $685097.0 in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $2.6 million in Q4 2021 and troughed at $504642.0 in Q2 2024.
  • A 5-year average of $1.7 million and a median of $2.0 million in 2022 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: crashed 73.63% in 2024 and later surged 97.32% in 2025.
  • Year by year, Cash & Equivalents stood at $2.6 million in 2021, then decreased by 8.51% to $2.4 million in 2022, then fell by 24.91% to $1.8 million in 2023, then fell by 29.6% to $1.2 million in 2024, then plummeted by 40.02% to $746001.0 in 2025.
  • Business Quant data shows Cash & Equivalents for LCTC at $746001.0 in Q4 2025, $685097.0 in Q3 2025, and $995750.0 in Q2 2025.